Open access
Jul 2026
Cost-effectiveness analysis of a hypothetical vaccine for schistosomiasis in Madagascar and Burkina Faso.
Schistosomiasis vaccination has the potential to be a cost-effective intervention, although its economic value depends strongly on vaccine characteristics, implementation costs, and the target population.
Y. Hwang, G. E. Cakpo, N. Rakotozandrindrainy et al.
· Vaccine · 0 citations